lifestyle.capitolhilltimes.com

Author: Ayrmid Pharma Ltd

Ayrmid Appoints ACA Pharma as Exclusive Distributor for Omisirge(R) across Greater China and Southeast Asia

February 12, 2026
Ayrmid and Ariti Sign Distribution Agreement for Omisirge(R) in Greece and Cyprus

February 11, 2026
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM

February 11, 2026
Ayrmid Reports Additional New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease and Beta-Thalassemia

February 11, 2026
Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia Presented at ASH

December 8, 2025
Ayrmid Presents New Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease

December 8, 2025